Severe Toxoplasma gondii infection in a member of a NFKB2-deficient family with T and B cell dysfunction

Affiliations

• ¹ San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Pediatric Immunohematology Unit, San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
• ² University Department of Pediatrics, Unit of Immune and Infectious Diseases, Childrens' Hospital Bambino Gesù, Italy.
• ³ Crs4, Biomedicine, Pula, CA, Italy; IRGB CNR, Cittadella Universitaria, Monserrato, CA, Italy.
• ⁴ University Department of Pediatrics, Endocrinology Unit, Childrens' Hospital Bambino Gesù, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
• ⁵ University Department of Pediatrics, Unit of Immune and Infectious Diseases, Childrens' Hospital Bambino Gesù, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
• ⁶ University Department of Pediatrics, Endocrinology Unit, Childrens' Hospital Bambino Gesù, Italy.
• ⁷ Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
• ⁸ Department of Imaging, Neuroradiology Unit, Childrens' Hospital Bambino Gesù, Italy.
• ⁹ Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
• ¹⁰ Immuno-Infectivology and Clinical Trials Research Area, Children's Hospital Bambino Gesù, Rome, Italy.
• ¹¹ B Cell Physiopathology Unit, Immunology Research Area, Children's Hospital Bambino Gesù, Rome, Italy.
• ¹² Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: [email protected].
• ¹³ University Department of Pediatrics, Unit of Immune and Infectious Diseases, Childrens' Hospital Bambino Gesù, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. Electronic address: [email protected].